Kilitch Drugs (India) Limited (NSE:KILITCH)

Kilitch Drugs (India) Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Revenue	2,080	1,983	1,544	1,396	1,142	685.23
Revenue Growth (YoY)	37.51%	28.47%	10.58%	22.20%	66.71%	28.51%
Cost of Revenue	1,115	1,053	793.92	754.16	673.86	379.13
Gross Profit	964.96	930.05	749.8	641.83	468.49	306.11
Selling, General & Admin	330.84	312.74	239.66	231.58	117.14	97.23
Other Operating Expenses	303.42	302.66	262.1	234.61	234.96	156.1
Operating Expenses	665.28	638.08	526.82	493.27	368.33	264.76
Operating Income	299.69	291.97	222.98	148.56	100.16	41.34
Interest Expense	-48.4	-50.41	-59.29	-49.19	-11.98	-7.54
Interest & Investment Income	-	36	4.2	3.1	2.5	2.26
Earnings From Equity Investments	-	0	0.02	0.02	-0.02	-0.02
Currency Exchange Gain (Loss)	-	28.07	19.96	15.6	-2.29	9.76
Other Non Operating Income (Expenses)	111.44	7.93	0.22	0.59	2.62	1.8
EBT Excluding Unusual Items	362.73	313.57	188.09	118.69	90.98	47.59
Impairment of Goodwill	-	-8.43	-8.43	-8.43	-8.43	-8.43
Gain (Loss) on Sale of Investments	-	39.6	13.89	9.88	13.59	12.03
Pretax Income	362.73	344.74	193.55	120.14	96.14	51.2
Income Tax Expense	91.82	95.34	57.79	37.32	34.01	13.53
Earnings From Continuing Operations	270.91	249.4	135.75	82.83	62.14	37.67
Minority Interest in Earnings	12.96	17.61	10.26	21.65	11.54	-0.96
Net Income	283.86	267.01	146.01	104.48	73.67	36.71
Net Income to Common	283.86	267.01	146.01	104.48	73.67	36.71
Net Income Growth	125.56%	82.86%	39.75%	41.82%	100.68%	336.00%
Shares Outstanding (Basic)	16	16	16	16	16	15
Shares Outstanding (Diluted)	16	16	16	16	16	15
Shares Change (YoY)	0.09%	0.96%	2.23%	0.10%	0.56%	0.37%
EPS (Basic)	17.66	16.60	9.17	6.71	4.73	2.37
EPS (Diluted)	17.66	16.60	9.17	6.71	4.73	2.37
EPS Growth	125.35%	81.10%	36.71%	41.76%	99.58%	334.09%
Free Cash Flow	-	-293.31	-79.85	-12.26	-24.19	93.61
Free Cash Flow Per Share	-	-18.24	-5.01	-0.79	-1.55	6.05
Gross Margin	46.39%	46.90%	48.57%	45.98%	41.01%	44.67%
Operating Margin	14.41%	14.72%	14.44%	10.64%	8.77%	6.03%
Profit Margin	13.65%	13.46%	9.46%	7.48%	6.45%	5.36%
Free Cash Flow Margin	-	-14.79%	-5.17%	-0.88%	-2.12%	13.66%
EBITDA	332.57	313.56	246.36	175.51	116.29	52.75
EBITDA Margin	15.99%	15.81%	15.96%	12.57%	10.18%	7.70%
D&A For EBITDA	32.88	21.59	23.38	26.96	16.13	11.41
EBIT	299.69	291.97	222.98	148.56	100.16	41.34
EBIT Margin	14.41%	14.72%	14.44%	10.64%	8.77%	6.03%
Effective Tax Rate	25.31%	27.66%	29.86%	31.06%	35.37%	26.43%
Revenue as Reported	2,192	2,095	1,589	1,425	1,171	711.91

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.